In just one year after the initial discovery of RNF43 mutations in IPMN and MCN, recurrent RSPO2 and RSPO3 translocations were identified in 3.0% and 8.0% of colon cancer, respectively [47]. Here, RNF43 is linked to pancreatic intraductal papillary-mucinous neoplasm.